Support The Moscow Times!

Russia Eyes First Coronavirus Vaccine Launch in Mid-August

Russia is one of several countries racing to develop the sought-after coronavirus vaccine. Moskva News Agency

Russian scientists said Monday they hope the world’s first coronavirus vaccine will be distributed to patients as soon as next month after a medical university in Moscow said it completed clinical trials using human volunteers.

The Sechenov First Moscow State Medical University launched clinical trials of the potential Covid-19 vaccine on 38 paid volunteers in June. Around the same time, Russia’s military began a parallel two-month clinical trial of the same vaccine developed by the state-run Gamaleya National Research Center for Epidemiology and Microbiology.

The Gamaleya center's head Alexander Gintsburg told the state-run TASS news agency that he hopes the vaccine will “enter civil circulation” on Aug. 12-14. He added that he hopes private companies would begin mass production by September.

The research has been completed and it proved that the vaccine is safe,” Yelena Smolyarchuk, the head of the Sechenov University’s clinical research center, told TASS of its trial.

The Sechenov University's two groups of volunteers will be discharged Wednesday and next Monday after spending 28 days in isolation to protect them from exposure to other infections, she added. The volunteers, aged 18 to 65, will be monitored for six more months after their release.

Earlier in July, Smolyarchuk said that some participants experienced typical responses to injections, such as headaches and an elevated body temperature, which resolved within 24 hours.

“The Russian Health Ministry will make a decision on the substance effectiveness based on the results of” biochemical tests, the university said in a July 3 press release.

The ministry “hopes to finalize the trials ... before fall,” it added.

The Gamaleya Research Center said earlier in May that its own scientists were self-administering the vaccine, a move criticized by some experts.

The decision to involve the general public in vaccine trials underscores Russia’s desire to move ahead fast with its testing of the sought-after coronavirus vaccine.

Russia has the world’s fourth-highest number of coronavirus infections after the United States, Brazil and India. The Kremlin has previously said the nation’s scientists are working on almost 50 different vaccine projects, while scientists have said developing a vaccine is "a question of national prestige.”

Though the race to develop a vaccine that would help the population develop herd immunity is in full swing around the world, recent research suggests that asymptomatic patients could have a weaker immune response to Covid-19 because their antibodies fade as early as two months after infection.

… we have a small favor to ask. As you may have heard, The Moscow Times, an independent news source for over 30 years, has been unjustly branded as a "foreign agent" by the Russian government. This blatant attempt to silence our voice is a direct assault on the integrity of journalism and the values we hold dear.

We, the journalists of The Moscow Times, refuse to be silenced. Our commitment to providing accurate and unbiased reporting on Russia remains unshaken. But we need your help to continue our critical mission.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and you can be confident that you're making a significant impact every month by supporting open, independent journalism. Thank you.

paiment methods
Not ready to support today?
Remind me later.

Read more